Mostrar el registro sencillo del ítem

dc.contributor.authorGil-Guillen, Vicente F
dc.contributor.authorBalsa, Alejandro
dc.contributor.authorBernárdez, Beatriz
dc.contributor.authorValdés Y Llorca, Carmen
dc.contributor.authorMárquez-Contreras, Emilio
dc.contributor.authorde la Haba-Rodríguez, Juan
dc.contributor.authorCastellano, Jose M
dc.contributor.authorGómez-Martínez, Jesús
dc.date.accessioned2023-04-27T11:04:17Z
dc.date.available2023-04-27T11:04:17Z
dc.date.issued2022-09-23
dc.identifier.citationInt J Environ Res Public Health. 2022 Sep 23;19(19):12036.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15920
dc.description.abstractMedication adherence is directly associated with health outcomes. Adherence has been reviewed extensively; however, most studies provide a narrow scope of the problem, covering a specific disease or treatment. This project's objective was to identify risk factors for non-adherence in the fields of rheumatology, oncology, and cardiology as well as potential interventions to improve adherence and their association with the risk factors. The project was developed in three phases and carried out by a Steering Committee made up of experts from the fields of rheumatology, oncology, cardiology, general medicine, and hospital and community pharmacy. In phase 1, a bibliographic review was performed, and the articles/reviews were classified according to the authors' level of confidence in the results and their clinical relevance. In phase 2, 20 risk factors for non-adherence were identified from these articles/reviews and agreed upon in Steering Committee meetings. In phase 3, potential interventions for improving adherence were also identified and agreed upon. The results obtained show that adherence is a dynamic concept that can change throughout the course of the disease, the treatments, and other factors. Educational interventions are the most studied ones and have the highest level of confidence in the authors' opinion. Information and education are essential to improve adherence in all patients.es_ES
dc.description.sponsorshipThis Project was funded and sponsored by Pfizer.es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshCardiology es_ES
dc.subject.meshRheumatology es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMedication Adherence es_ES
dc.subject.meshRisk Factors es_ES
dc.titleMedication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.es_ES
dc.typereviewes_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID36231341es_ES
dc.format.volume19es_ES
dc.format.number19es_ES
dc.identifier.doi10.3390/ijerph191912036es_ES
dc.contributor.funderPfizer es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1660-4601es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/ijerph191912036es_ES
dc.identifier.journalInternational journal of environmental research and public healthes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Imagen Cardiovascular y Estudios Poblacionaleses_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional